Found vs Maximus
Found costs $50.99 less a month, and both sell semaglutide, tirzepatide and orforglipron.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Maximus
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Maximus →If you are choosing between Found and Maximus, the first difference is cost: Found is $50.99 a month cheaper at the entry price. Both prescribe semaglutide, tirzepatide and orforglipron, so moving from one to the other would not change your drug. Found leads our six-part score, 8.6 to 6.5. One of the two has an FDA warning letter on record, covered below.
Found vs Maximus price
Found is the cheaper way in: $149 a month against $199.99 a month at Maximus. That is $50.99 less each month (25% lower), or about $611.88 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Found ($169 a month vs $249.99 a month); tirzepatide is cheaper at Found ($169 a month vs $359.99 a month); orforglipron is cheaper at Found ($149 a month vs $199.99 a month).
Medications and formats
Both sell semaglutide, tirzepatide and orforglipron.
On format, Found prices compounded injections, an oral option and brand-name pens, while Maximus prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, Found is the only one of the two with a brand-name price.
Where each one treats patients
Found lists 50 states, and Maximus lists 51 states.
They overlap in 50 states. Maximus alone covers District of Columbia.
Pricing
Found
$169/mo cash-pay on the 12-month prepaid plan, with medication, membership and coaching included; $99/mo with insurance on the same 12-month prepaid plan. Month-to-month: $199/mo with insurance, $289/mo cash. A '$100 off today' promo was running at checkout.
Same Compounded GLP-1 Plan price as semaglutide, with no per-drug price published; the drug and price are set after intake. Cash: $169/mo prepaid for 12 months or $289/mo month to month. Insurance: $99/mo prepaid.
Starting cash price of about $149/mo, listed on Found's Foundayo comparison table. Newly added to Found's menu.
Homepage carousel 'Wegovy® from $650/mo+'; but /medication/foundayo table lists 'Wegovy® Pen ... Starting cash price ~$199/mo' — internally inconsistent on their own site.
Homepage carousel 'Zepbound® from $650/mo+'; /medication/foundayo table shows Zepbound ~$299/mo starting cash price.
Brand-name Ozempic at $1,100/mo, as advertised on the homepage.
Homepage carousel 'Mounjaro® ~$1100/mo' — unchanged. Non-GLP-1 generics plan from $49/mo; microdosing program price not published.
Maximus
4-Month plan $199/mo; 12-Month plan $150/mo ('BEST VALUE... Save $100'); homepage teaser 'GLP-1 Starting at $149.99'; /weight-loss hub also shows 'Starting at $116 /28-day supply' (teaser, unreconciled with product page)
4-Month plan $299/mo; 12-Month plan $240/mo; product page 'Personalized doses from $198 /mo' and hub 'Starting at $198 /28-day supply'; homepage teaser 'GLP-1 + GIP Starting at $249.99'
NEW: brand-name oral GLP-1; 'Foundayo starting at $199.99 /mo'
NEW brand-name option
NEW brand-name option
NEW brand-name option
NEW brand-name option; multi-dose KwikPen at same self-pay price as vial
NEW brand-name option; on-label tirzepatide
What each price covers
Both prices cover the medication itself.
Found's price also covers the clinician visit and coaching, which Maximus does not claim.
Maximus' price also covers shipping, which Found does not claim.
Found is silent on shipping and lab work.
Maximus is silent on the clinician visit, lab work and coaching.
Found
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Maximus
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Found scores 8.6 and Maximus 6.5 out of 10.
Found is stronger on value (7.8 vs 2.8), user experience (8.0 vs 7.5), trust & safety (8.5 vs 4.5) and support (7.0 vs 4.5).
Effectiveness and accessibility are within half a point.
Found
8.6/10
Maximus
6.5/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Maximus a warning letter dated June 8, 2026 (letter 730095), and it is still open.
Found has no FDA warning letter on record with us.
Features & Coverage
| Feature | Found | Maximus |
|---|---|---|
| Starting Price | ✓$149/mo | $199.99/mo |
| Features | 3 features | ✓5 features |
| States Available | 50 | ✓51 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 1 letter |
About Found
Found is a personalized weight care platform. It runs on a self-pay membership, and medication costs sit on top of that.
Read our full Found review →About Maximus
Maximus is a men's health platform selling compounded semaglutide from $149.99/mo on a 12-month plan, plus compounded tirzepatide, alongside testosterone replacement therapy and longevity treatments. It covers all 50 states plus DC, and a microdose protocol is available for patients with less weight to lose.
Read our full Maximus review →Pros & Cons
Found
What we like
- Tirzepatide costs $169 a month, 32% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and coaching
- Serves all 50 states
- We found no FDA warning letters issued to Found
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its orforglipron, semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Maximus
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication and shipping
- Serves all 50 states
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
Watch-outs
- Semaglutide costs $249.99 a month, 36% above the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $359.99 a month, 44% above the $250 median for compounded tirzepatide across the sellers we compare
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Maximus a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its orforglipron, semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Found wins this one, 8.6 to 6.5, above all for tirzepatide at $169/month, 37% below the typical price. It also costs $50.99 less each month than Maximus. Maximus fits better if coverage in all 50 states, which most sellers will not confirm is your priority.
Choose Found if…
You want tirzepatide at $169/month, 37% below the typical price and an opening price near $149 a month.
Choose Maximus if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199.99 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →Found vs Maximus: FAQ
Close alternatives to Found and Maximus
- Found vs Sesame Care
- Found vs ShedRx
- Found vs Kin Meds
- Found vs PreventiveMD
- Maximus vs ShedRx
- Maximus vs Kin Meds
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.